1067952

Stason Pharmaceuticals, Inc. — FEI 1000160561

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 24, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Irvine, CA (United States)